COVALENT GROUP INC
8-K, 1998-01-08
LABORATORY ANALYTICAL INSTRUMENTS
Previous: MFS SPECIAL VALUE TRUST, N-30D, 1998-01-08
Next: NORTH AMERICAN VACCINE INC, SC 13D/A, 1998-01-08



<PAGE>
 
                      SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                    FORM 8-K
                                 CURRENT REPORT

                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                        SECURITIES EXCHANGE ACT OF 1934



      Date of Report (Date of earliest event reported): December 31, 1997



                              COVALENT GROUP, INC.
                              --------------------
                 (Exact name of issuer as specified in charter)



<TABLE>
<S>                         <C>                             <C>
    NEVADA                           0-21145                     23-561668867
(State or Other                    (Commission                 (I.R.S. Employer
 Jurisdiction                         file                      Identification
of Incorporation                     number)                        Number)
or Organization)
</TABLE>



                        ONE GLENHARDIE CORPORATE CENTER
                               1275 DRUMMERS LANE
                                   SUITE 100
                           WAYNE, PENNSYLVANIA 19087
                    (Address of principal executive offices)


                                 (610) 975-9533
              (Registrant's telephone number, including area code)
<PAGE>
 
ITEM 4.   CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANT

          On December 31, 1997, Covalent Group, Inc. (the "Company") replaced
          Baratz & Associates, P.A. ("Baratz"), its independent public
          accountants, with Arthur Andersen LLP ("Andersen").  Baratz previously
          audited the Company's financial statements for the years ended
          December 31, 1996 and 1995.

          The report of Baratz on the Company's consolidated financial
          statements for the years ended December 31, 1996 and 1995 did not
          contain an adverse opinion or a disclaimer of opinion and was not
          qualified or modified as to uncertainty, audit scope or accounting
          principles.  During the last two years there were no disagreements
          with Baratz on any matter of accounting principles or practices,
          financial statement disclosure or auditing scope or procedure.

          The decision of the Company to replace Baratz with Andersen as the
          Company's independent public accountants was unanimously approved by
          the Board of Directors and approved by the Company's stockholders at
          its annual meeting on September 16, 1997.

          Pursuant to Item 304(a)(3) of Regulation S-B, the Company has
          requested Baratz to furnish it a letter addressed to the Securities
          and Exchange Commission stating whether it agrees with the above
          statements.  A copy of that letter is filed as an Exhibit to this Form
          8-K.

ITEM 7.   FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS

          Exhibits

               16   Letter from Baratz to the Company dated January 7, 1998.

                         SIGNATURE

Pursuant to the requirements of the Securities and Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned duly authorized.

Date: January 7, 1998                         Covalent Group, Inc.


                                             /s/ William K. Robinson
                                             ----------------------------------
                                             William K. Robinson
                                             Chief Financial Officer
<PAGE>
 
                                 EXHIBIT INDEX

EXHIBIT
  NO.                    DESCRIPTION
- -------                  -----------

16             Letter from Baratz & Associates, P.A. dated January 7, 1998.

<PAGE>
 
                                                                      Exhibit 16

January 7, 1998

Securities and Exchange Commission
450 Fifth Street, N.W.
Washington, D.C.  20549



Gentlemen:

We have read Item 4 included in the Form 8-K dated December 31, 1997 of Covalent
Group, Inc. to be filed with the Securities and Exchange Commission on January
7, 1998 and are in agreement with the statements contained therein.

Very truly yours,

/s/BARATZ & ASSOCIATES, P.A.

BARATZ & ASSOCIATES, P.A.


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission